Jefferies Keeps Quantinuum at Buy Rating
Jefferies has maintained its Buy rating on Quantinuum, according to Dow Jones Newswires. The report offers few further details.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Dow Jones Newswires reports that Jefferies has kept its Buy rating on Quantinuum shares. The item contains little beyond that statement and a link to Benzinga's analyst ratings page for the QNT ticker.
why it matters
A single bank reaffirming a rating rarely moves the broader market. For QNT investors it signals that the analyst's positive view is unchanged, but the report includes no new financial data.
tags
instruments
sources
- Quantinuum Is Maintained at Buy by Jefferies — Dow Jones Newswires, 7 November 2026 at 00:33 UTC
- Arteris Is Maintained at Buy by Jefferies — Dow Jones Newswires, 7 November 2026 at 00:36 UTC
- IonQ Is Maintained at Buy by Jefferies — Dow Jones Newswires, 7 November 2026 at 00:34 UTC
- Interparfums Is Maintained at Buy by Jefferies — Dow Jones Newswires, 7 November 2026 at 00:45 UTC
- Targa Resources Is Maintained at Buy by Jefferies — Dow Jones Newswires, 7 November 2026 at 00:51 UTC
- Inovio Pharma Is Maintained at Buy by Jefferies — Dow Jones Newswires, 7 November 2026 at 00:53 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗